← Browse by Condition
Medical Condition

hormone receptor negative tumor

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05582499 Phase 2
Recruiting

Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy

Enrollment
716 pts
Location
China
Sponsor
Fudan University
View Trial →